Sofosbuvir/Ledipasvir Without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence After Liver Transplantation: Two-Center Experience

@article{Elfeki2017SofosbuvirLedipasvirWR,
  title={Sofosbuvir/Ledipasvir Without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence After Liver Transplantation: Two-Center Experience},
  author={Mohamed A. Elfeki and Rachel Abou Mrad and Jamak Modaresi Esfeh and Nizar N. Zein and Bijan Eghtesad and Xaralambos Zervos and Ibrahim A. Hanouneh and Robert O'Shea and William D. Carey and Naim Alkhouri},
  journal={Transplantation},
  year={2017},
  volume={101},
  pages={996–1000}
}
  • Mohamed A. Elfeki, Rachel Abou Mrad, +7 authors Naim Alkhouri
  • Published in Transplantation 2017
  • Medicine
  • Background Current recommended regimens to treat patients with hepatitis C virus (HCV) infection after liver transplantation include the use of ribavirin (RBV). Limited data are available on the efficacy of RBV-free regimens posttransplant, particularly the use of sofosbuvir (SOF)/ledipasvir (LDV) without RBV in this patient population. We aimed to assess the efficacy and safety of SOF/LDV fixed-dose combination without RBV in patients with HCV recurrence posttransplant. Methods This is a… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    1
    Twitter Mention

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 10 CITATIONS

    Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience

    VIEW 10 EXCERPTS
    CITES RESULTS, METHODS & BACKGROUND
    HIGHLY INFLUENCED

    Increasing access to thoracic organs from donors infected with hepatitis C: A previous challenge-now an opportunity.

    • Ann E Woolley, Lindsey Robert Baden
    • Medicine
    • The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
    • 2018

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 36 REFERENCES

    Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation.

    VIEW 2 EXCERPTS

    Hepatitis C Virus

    Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.

    VIEW 2 EXCERPTS